Hyundai Bio and DNDi sign MoU for joint development of Xafty-based dengue treatment

South Korea-based Hyundai Bioscience, and the Drugs for Neglected Diseases initiative (DNDi), an international non-profi...

February 6, 2025 | Thursday | News
Taiwan unveils groundbreaking advancements in AI-driven drug discovery and cancer therapy

By partnering with Kyoto University in Japan, China Medical University (CMU) and Healthcare System in Taiwan has es...

February 5, 2025 | Wednesday | News
Korea pioneers new future in advanced biotechnology

The Ministry of Science and ICT and the Korea Research Institute of Bioscience and Biotechnology have announced the "Top...

February 5, 2025 | Wednesday | News
Australia's AdvanCell closes oversubscribed Series C financing of $112 M

AdvanCell, a clinical-stage radiopharmaceutical company developing innovative cancer treatments, has closed an oversubsc...

February 4, 2025 | Tuesday | News
Chugai and GSK sign collaboration agreement for anti-dengue virus antibody AID351

Japan's Chugai Pharmaceutical Co. has signed a collaboration agreement with GSK's Global Health Unit (GSK GH) for&n...

January 31, 2025 | Friday | News
“China and Asia are already the global leaders of Antibody-drug conjugates”

Chime Biologics has a vision to make biologics more accessible and affordable. How does this vision drive your day-to-da...

February 1, 2025 | Saturday | Opinion
Accelerating Cancer Treatment with Precision Medicine & NGS

Cancer is inherently diverse, with significant variations both between different tumours and among individuals. This var...

February 1, 2025 | Saturday | Analysis
APAC takes centre-stage in AI-driven drug discovery

Drug discovery is a lengthy and costly process, typically requiring billions of dollars and nearly a decade to bring a d...

February 1, 2025 | Saturday | Analysis
Japan's ThinkCyte expands product portfolio to drive innovation in drug discovery and disease research

Japan-based startup ThinkCyte, a biotechnology company pioneering novel artificial intelligence (AI)-based cell analysis...

January 29, 2025 | Wednesday | News
AB2 Bio signs licensing agreement worth $500 M with Nippon Shinyaku for ultra-rare autoimmune disease treatment

AB2 Bio, a biotechnology company developing innovative therapies for the treatment of severe systemic hyperinflammatory ...

January 28, 2025 | Tuesday | News
Renascience to open branch lab of Northwestern University Longevity Institute in Japan

Japanese firm Renascience has concluded a joint research agreement on ageing with Prof. Douglas E. Vaughan, Direct...

January 24, 2025 | Friday | News
Biophytis and AskHelpU sign co-development agreement to treat rare neuromuscular diseases in China

Biophytis SA, a Paris-based clinical-stage biotechnology company specialising in the development of treatments for age-r...

January 23, 2025 | Thursday | News
Korea's GI Innovation & LaNova Medicines sign MoU for pancreatic cancer combination therapy

South Korea's GI Innovation has signed a Memorandum of Understanding (MoU) with LaNova Medicines for the development of ...

January 23, 2025 | Thursday | News
US-Korea enter into joint investment collaboration for biopharma

GordonMD Global Investments LP, a US-based investment manager focused exclusively on global public and private biop...

January 21, 2025 | Tuesday | News
Germany's BioMed X Institute launches new collaboration with Japanese firm Daiichi Sankyo in cancer therapy

BioMed X, an independent biomedical research institute based in Heidelberg, Germany, has announced the launch of a new c...

January 16, 2025 | Thursday | News
HKUST signs MoU with Microsoft Research Asia fostering collaboration in future medical education and research

The Hong Kong University of Science and Technology (HKUST) has signed a Memorandum of Understanding (MoU) with Microsoft...

January 15, 2025 | Wednesday | News
Health Research Council in New Zealand puts $4.3 M into University projects

More than $4.3 million from the Health Research Council in New Zealand will allow University of Auckland researchers to ...

January 13, 2025 | Monday | News
Australia's Telix Pharma buys next-gen therapeutic assets from ImaginAb

Australia-based Telix Pharmaceuticals has entered into an asset purchase agreement with US-based antibody engineering co...

January 13, 2025 | Monday | News